O'Higgins N - Search Results

1

A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.

Di Leo A, Crown J, Nogaret JM, Duffy K, Bartholomeus S, Dolci S, Rowan S, O'Higgins N, Paesmans M, Larsimont D, Riva A, Piccart MJ. Di Leo A, et al. Ann Oncol. 2000 Feb;11(2):169-75. doi: 10.1023/a:1008345432342. Ann Oncol. 2000. PMID: 10761751 Free article. Clinical Trial.

2

ADAM-17 predicts adverse outcome in patients with breast cancer.

McGowan PM, McKiernan E, Bolster F, Ryan BM, Hill AD, McDermott EW, Evoy D, O'Higgins N, Crown J, Duffy MJ. McGowan PM, et al. Ann Oncol. 2008 Jun;19(6):1075-81. doi: 10.1093/annonc/mdm609. Epub 2008 Jan 30. Ann Oncol. 2008. PMID: 18238782 Free article.

3

Assay of E-cadherin by ELISA in human breast cancers.

Maguire TM, Shering SG, McDermott EW, O'Higgins N, Fennelly JJ, Crown J, Duffy MJ. Maguire TM, et al. Eur J Cancer. 1997 Mar;33(3):404-8. doi: 10.1016/s0959-8049(97)89013-2. Eur J Cancer. 1997. PMID: 9155524

4

Surgical intervention in screen-detected patients versus symptomatic patients with breast cancer.

Dillon MF, Hill AD, Quinn CM, O'Doherty A, Crown J, Fleming FJ, McDermott EW, O'Higgins N. Dillon MF, et al. J Med Screen. 2004;11(3):130-4. doi: 10.1258/0969141041732238. J Med Screen. 2004. PMID: 15333271

5

Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancer.

Nugent A, McDermott E, Duffy K, O'Higgins N, Fennelly JJ, Duffy MJ. Nugent A, et al. Clin Chem. 1992 Aug;38(8 Pt 1):1471-4. Clin Chem. 1992. PMID: 1353709

6

Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.

Ryan B, O'Donovan N, Browne B, O'Shea C, Crown J, Hill AD, McDermott E, O'Higgins N, Duffy MJ. Ryan B, et al. Br J Cancer. 2005 Jan 17;92(1):120-4. doi: 10.1038/sj.bjc.6602314. Br J Cancer. 2005. PMID: 15611790 Free PMC article.

7

Pregnancy-associated breast cancer.

Healy C, Dijkstra B, Kelly L, McDermott EW, Hill AD, O'Higgins N. Healy C, et al. Ir Med J. 2002 Feb;95(2):51-2, 54. Ir Med J. 2002. PMID: 11989949

8

Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.

Remacle AG, Noël A, Duggan C, McDermott E, O'Higgins N, Foidart JM, Duffy MJ. Remacle AG, et al. Br J Cancer. 1998 Mar;77(6):926-31. doi: 10.1038/bjc.1998.153. Br J Cancer. 1998. PMID: 9528836 Free PMC article.

9

Lack of prognostic effect of Cox-2 expression in primary breast cancer on short-term follow-up.

Kelly LM, Hill AD, Kennedy S, Connolly EM, Ramanath R, Teh S, Dijkstra B, Purcell R, McDermott EW, O'Higgins N. Kelly LM, et al. Eur J Surg Oncol. 2003 Nov;29(9):707-10. doi: 10.1016/j.ejso.2003.07.001. Eur J Surg Oncol. 2003. PMID: 14602487

10

Tamoxifen as the primary treatment in elderly patients with breast cancer.

Hooper SB, Hill AD, Kennedy S, Dijkstra B, Kelly LM, McDermott EW, O'Higgins N. Hooper SB, et al. Ir J Med Sci. 2002 Jan-Mar;171(1):28-30. doi: 10.1007/BF03168937. Ir J Med Sci. 2002. PMID: 11993590

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters